FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elfriede Noessner

Research Profile

Disorders

Anatomy

Physiology

Chemicals & Drugs

Procedures

Flow Cytometry

Phenomena

Protein Binding

Co-author Network

Publications

TOP 3
Roghieh Djafarzadeh; Monika Hofstetter; Elfriede Noessner; Susan Notohamiprodjo; Nicole Rieth; Peter J Nelson
Treatment of dermal fibroblasts with GPI-anchored human TIMP-1 protein moderates processes linked to scar formation.
Murthy Narayana Darisipudi; Helen Liapis; Shrikant R Mulay; Elfriede Noessner; Dana Thomasova; Dorothee Brech; Hans-Joachim Anders
Uromodulin triggers IL-1β-dependent innate immunity via the NLRP3 inflammasome.
Anna N Mendler; Eva Gottfried; Bin Hu; Marina Kreutz; Petra U Prinz; Elfriede Noessner
Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elfriede Noessner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Roghieh Djafarzadeh; Monika Hofstetter; Elfriede Noessner; Susan Notohamiprodjo; Nicole Rieth; Peter J Nelson
Treatment of dermal fibroblasts with GPI-anchored human TIMP-1 protein moderates processes linked to scar formation.
The Journal of investigative dermatology 2013;133(3):803-11.
2012: Murthy Narayana Darisipudi; Helen Liapis; Shrikant R Mulay; Elfriede Noessner; Dana Thomasova; Dorothee Brech; Hans-Joachim Anders
Uromodulin triggers IL-1β-dependent innate immunity via the NLRP3 inflammasome.
Journal of the American Society of Nephrology : JASN 2012;23(11):1783-9.
2012: Anna N Mendler; Eva Gottfried; Bin Hu; Marina Kreutz; Petra U Prinz; Elfriede Noessner
Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activation.
International journal of cancer. Journal international du cancer 2012;131(3):633-40.
2012: Petra U Prinz; Ralph Oberneder; Leopold Durner; Ilias Masouris; Anna N Mendler; Elfriede Noessner
High DGK-α and disabled MAPK pathways cause dysfunction of human tumor-infiltrating CD8+ T cells that is reversible by pharmacologic intervention.
Journal of immunology (Baltimore, Md. : 1950) 2012;188(12):5990-6000.
2012: Henrik Gross; Christine Hennard; Elisabeth Kremmer; Heinrich Leonhardt; Alfredo Mamiani; Ilias Masouris; Bodo Moritz; Nils Neuenkirchen; Elfriede Noessner; Dirk H Ostareck; Antje Ostareck-Lederer; Ute Stober-Grässer; Stephanie Barth; Christian Cassel; Wen Deng; Utz Fischer; Friedrich A Grässer
Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression.
PloS one 2012;7(8):e42106.
2012: Roghieh Djafarzadeh; Pankaj Goyal; Susanne Himmelein; Elfriede Noessner; Susan Notohamiprodjo; Andrea Ribeiro; Matthias Sauter; Wolfgang Siess; Thomas Sitter; Markus Wörnle; Peter J Nelson
Recombinant GPI-anchored TIMP-1 stimulates growth and migration of peritoneal mesothelial cells.
PloS one 2012;7(4):e33963.
2012: Anna Jolesch; Henriette Bendz; Katharina Elmer; Rolf D Issels; Elfriede Noessner
Hsp70, a messenger from hyperthermia for the immune system.
European journal of cell biology 2012;91(1):48-52.
2011: Sonja Haupt; Raymond Lance; Christine Leib-Mösch; Elfriede Noessner; O John Semmes; Michele Tisdale; Adriana Turqueti-Neves; Michelle Vincendeau; Mary Anne Clements; David T Gauthier; Alex D Greenwood
Human endogenous retrovirus transcription profiles of the kidney and kidney-derived cell lines.
The Journal of general virology 2011;92(Pt 10):2356-66.
2011: Henrik Gross; Vladimir Gurtsevitch; Bin Hu; Elisabeth Kremmer; Nikolaus Mueller-Lantzsch; Elfriede Noessner; Thorsten Pfuhl; Martina Sauter; Andreas Spurk; Vivienne Willnecker; Stephanie Barth; Friedrich A Grässer
The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
International journal of cancer. Journal international du cancer 2011;129(5):1105-15.
2011: Ainhoa-M Figel; Ulrike K Lettenmeyer; Niklas Muenchmeier; Josef Mysliwietz; Peter J Nelson; David Anz; Dorothee Brech; Alexander Buchner; Judith Eckl; Stefan Porubsky; Petra U Prinz; Nicole Rieth; Stephan Segerer; Sabine I Siegert; Adriana Turqueti-Neves; Elfriede Noessner
Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations.
The American journal of pathology 2011;179(1):436-51.
2011: Elfriede Noessner; Maja Lindenmeyer; Peter J Nelson; Stephan Segerer
Dendritic cells in human renal inflammation--Part II.
Nephron. Experimental nephrology 2011;119(4):e91-8.
2011: Maja Lindenmeyer; Peter J Nelson; Elfriede Noessner; Stephan Segerer
Dendritic cells in experimental renal inflammation--Part I.
Nephron. Experimental nephrology 2011;119(4):e83-90.
2011: Susanne Harner; Elfriede Noessner; Korinna Nadas; Anke Leumann-Runge; Matthias Schiemann; Fabienne L Faber; Joachim Heinrich; Susanne Krauss-Etschmann
Cord blood Vα24-Vβ11 natural killer T cells display a Th2-chemokine receptor profile and cytokine responses.
PloS one 2011;6(1):e15714.
2010: Matthias Leisegang; Adriana Turqueti-Neves; Boris Engels; Thomas Blankenstein; Dolores Schendel; Wolfgang Uckert; Elfriede Noessner
T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(8):2333-43.
2009: Kathleen Ebelt; Gregor Babaryka; Bernhard Frankenberger; Christian G Stief; Wolfgang Eisenmenger; Thomas Kirchner; Dolores Schendel; Elfriede Noessner
Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters.
European journal of cancer (Oxford, England : 1990) 2009;45(9):1664-72.
2009: Maya J Pandya; Henriette Bendz; Florian Manzenrieder; Elfriede Noessner; Horst Kessler; Johannes Buchner; Rolf Issels
Interaction of human heat shock protein 70 with tumor-associated peptides.
Biological chemistry 2009;390(4):305-12.
2009: Roghieh Djafarzadeh; Valeria Milani; Nicole Rieth; Irene von Luettichau; Petra S Skrablin; Monika Hofstetter; Elfriede Noessner; Peter J Nelson
TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis.
Cancer immunology, immunotherapy : CII 2009;58(3):361-71.
2009: Dilip Kumar; Judith Hosse; Christine von Toerne; Elfriede Noessner; Peter J Nelson
JNK MAPK pathway regulates constitutive transcription of CCL5 by human NK cells through SP1.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(2):1011-20.
2008: Elke Bleifuss; Henriette Bendz; Birgit Sirch; Sylvia Thompson; Anna Brandl; Valeria Milani; Michael W Graner; Ingo Drexler; Maria Kuppner; Emmanuel Katsanis; Elfriede Noessner; Rolf Issels
Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2008;24(8):623-37.
2008: Henriette Bendz; Boris-Christian Marincek; Frank Momburg; Joachim W Ellwart; Rolf Issels; Peter J Nelson; Elfriede Noessner
Calcium signaling in dendritic cells by human or mycobacterial Hsp70 is caused by contamination and is not required for Hsp70-mediated enhancement of cross-presentation.
The Journal of biological chemistry 2008;283(39):26477-83.
2008: Maria C Kuppner; E Bleifuss; Elfriede Noessner; Ralph Mocikat; C von Hesler; C Mayerhofer; Rolf Issels
Differential effects of ifosfamide on dendritic cell-mediated stimulation of T cell interleukin-2 production, natural killer cell cytotoxicity and interferon-gamma production.
Clinical and experimental immunology 2008;153(3):429-38.
2008: Miran Javorovic; Susanne Wilde; Anke Zobywalski; Elfriede Noessner; Volker Lennerz; Thomas Wölfel; Dolores Schendel
Inhibitory effect of RNA pool complexity on stimulatory capacity of RNA-pulsed dendritic cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(1):52-62.
2008: Kathleen Ebelt; Gregor Babaryka; Ainhoa M Figel; Heike Pohla; Alexander Buchner; Christian G Stief; Wolfgang Eisenmenger; Thomas Kirchner; Dolores Schendel; Elfriede Noessner
Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma.
The Prostate 2008;68(1):1-10.
2007: Mechthild Krause; Marc Schmitz; Elfriede Noessner; Petra S A Skrablin; Rebekka Wehner; E Peter Rieber; Michael Baumann
Adoptive transfer of cytotoxic T-cells for treatment of residual disease after irradiation.
International journal of radiation biology 2007;83(11-12):827-36.
2007: Henriette Bendz; Sibylle C Ruhland; Maya J Pandya; Otmar Hainzl; Stefan Riegelsberger; Christoph Braüchle; Matthias P Mayer; Johannes Buchner; Rolf Issels; Elfriede Noessner
Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling.
The Journal of biological chemistry 2007;282(43):31688-702.
2007: Bernhard Frankenberger; Elfriede Noessner; Dolores Schendel
Immune suppression in renal cell carcinoma.
Seminars in cancer biology 2007;17(4):330-43.
2006: Daniel Sommermeyer; Julia Neudorfer; Monika Weinhold; Matthias Leisegang; Boris Engels; Elfriede Noessner; Mirjam H M Heemskerk; Jehad Charo; Dolores Schendel; Thomas Blankenstein; Helga Bernhard; Wolfgang Uckert
Designer T cells by T cell receptor replacement.
European journal of immunology 2006;36(11):3052-9.
2006: Stephan Segerer; Anna Henger; Holger Schmid; Matthias Kretzler; D Draganovici; Ulrike Brandt; Elfriede Noessner; Peter J Nelson; Dontscho Kerjaschki; Detlef Schlöndorff; Heinz Regele
Expression of the chemokine receptor CXCR1 in human glomerular diseases.
Kidney international 2006;69(10):1765-73.
2006: Roghieh Djafarzadeh; Elfriede Noessner; Hartmut Engelmann; Dolores Schendel; Mike Notohamiprodjo; Irene von Luettichau; Peter J Nelson
GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing.
Oncogene 2006;25(10):1496-508.
2006: Valeria Milani; Elfriede Noessner
Effects of thermal stress on tumor antigenicity and recognition by immune effector cells.
Cancer immunology, immunotherapy : CII 2006;55(3):312-9.
2006: Elfriede Noessner
Thermal stress-related modulation of tumor cell physiology and immune responses.
Cancer immunology, immunotherapy : CII 2006;55(3):289-91.
2006: Julia S Schleypen; Nicole Baur; Robert Kammerer; Peter J Nelson; Karl Rohrmann; Elisabeth F Gröne; Markus Hohenfellner; Axel Haferkamp; Heike Pohla; Dolores Schendel; Christine S Falk; Elfriede Noessner
Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 1):718-25.
2005: Christiane Geiger; Sybille Regn; Andreas Weinzierl; Elfriede Noessner; Dolores Schendel
A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma.
Journal of translational medicine 2005;3():29.
2005: Boris Engels; Elfriede Noessner; Bernhard Frankenberger; Thomas Blankenstein; Dolores Schendel; Wolfgang Uckert
Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes.
Human gene therapy 2005;16(7):799-810.
2005: Bernhard Frankenberger; Sybille Regn; Christiane Geiger; Elfriede Noessner; Christine S Falk; Heike Pohla; Miran Javorovic; Tobias Silberzahn; Susanne Wilde; Alexander Buchner; Michael Siebels; Ralph Oberneder; Gerald Willimsky; Antonio Pezzutto; Thomas Blankenstein; Dolores Schendel
Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells.
World journal of urology 2005;23(3):166-74.
2005: Bernhard Frankenberger; Heike Pohla; Elfriede Noessner; Gerald Willimsky; Britta Papier; Antonio Pezzutto; Joachim Kopp; Ralph Oberneder; Thomas Blankenstein; Dolores Schendel
Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(5):1733-42.
2005: Valeria Milani; Bernhard Frankenberger; Oksana Heinz; Anna Brandl; Sibylle Ruhland; Rolf Issels; Elfriede Noessner
Melanoma-associated antigen tyrosinase but not Melan-A/MART-1 expression and presentation dissociate during the heat shock response.
International immunology 2005;17(3):257-68.
2004: Dolores Schendel; Christine S Falk; Bernhard Frankenberger; Elfriede Noessner; Julia S Schleypen; Heike Pohla
The cellular and molecular basis of natural antitumor immunity in renal cell carcinoma patients.
Der Urologe. Ausg. A 2004;43 Suppl 3():S133-5.
2004: Valeria Milani; M Endres; Maria C Kuppner; Rolf Issels; Elfriede Noessner
[Heat shock proteins, immune competence and vaccination].
Deutsche medizinische Wochenschrift (1946) 2004;129(1-2):31-5.
2002: Elfriede Noessner; Robert Gastpar; Valeria Milani; Anna Brandl; Peter J S Hutzler; Maria C Kuppner; Miriam Roos; Elisabeth Kremmer; Alexzander Asea; Stuart K Calderwood; Rolf Issels
Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(10):5424-32.
2002: Valeria Milani; Elfriede Noessner; S Ghose; Maria C Kuppner; B Ahrens; Anabel Scharner; Robert Gastpar; Rolf Issels
Heat shock protein 70: role in antigen presentation and immune stimulation.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2002;18(6):563-75.
2002: Christine S Falk; Elfriede Noessner; Elisabeth H Weiss; Dolores Schendel
Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cells.
Cancer research 2002;62(2):480-7.
2001: C Huck; Josef Endl; T Walk; Elfriede Noessner; G Jung; R Wank; Dolores Schendel
HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
Diabetologia 2001;44(1):70-80.